SCHEMBL686712

SCHEMBL686712

O=C(O)C[C@H](NC(=O)Nc1ccc(=O)n(Cc2ccccc2)c1)c1ccc2c(c1)OCO2

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.52
ITGAV P06756 1/20 0.52
ITGA2B P08514 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
HTT P42858 1/20 0.48
GSK3B P49841 1/20 0.47
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
POLB P06746 1/20 0.44
TP53 P04637 1/20 0.44
THRB P10828 1/20 0.44
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687571 0.84 ALDH1A1 (0.50) ITGB3ITGAVITGA2BSMN1; SMN2KMT2A
SCHEMBL688097 0.80 ITGB1 (0.58) RAB9ANPC1
SCHEMBL687813 0.80 ITGB3 (0.44) ITGB3ITGAVITGA2BMAPTTP53
SCHEMBL3141349 0.78 ITGB3 (0.58) ITGB3ITGAVITGA2BKMT2AMEN1
SCHEMBL688325 0.78 ALDH1A1 (0.51) ITGB3ITGAVITGA2BSMN1; SMN2KMT2A
SCHEMBL695420 0.78 MAPT (0.54) ITGB3ITGA2BSMN1; SMN2KMT2AMEN1
SCHEMBL688224 0.78 PTGER3 (0.51) ITGB3ITGAVITGA2BKMT2AMEN1
SCHEMBL686731 0.77 MAPT (0.55) SMN1; SMN2KMT2AMEN1RAB9AMAPT
SCHEMBL687428 0.77 PTGER3 (0.56) ITGB3ITGAVSMN1; SMN2KMT2AMEN1
SCHEMBL688073 0.77 ALDH1A1 (0.44) ITGB3ITGAVITGA2BSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed